A new multimodal tool combines a large language model with powerful graph-based AI models to efficiently find new, synthesizable molecules with desired properties, based on a user's queries in plain ...

At the heart of BioClick is a focus on group transfer reactions, a class of biochemical reactions that allow enzymes to precisely move small molecular chemical groups from one compound to another.

Chemists and chemical engineers at California Institute of Technology, working with a pair of colleagues from the University ...

A new study published in Engineering explores the biomimetic synthesis of natural products. This research, led by scientists ...

Skoltech scientists discovered over 200 carbon-oxygen compounds with high energy potential, some rivaling TNT, offering new ...

A new company has entered the drug discovery space with what it calls a “chemistry-first” platform. Colorado-based Cime ...

In 2024, not one but two Nobel Prizes (in Chemistry and Physics) were awarded to researchers for their work in artificial intelligence ...

The solketal market size stands at USD 80.9 million in 2024 and is anticipated to surpass a valuation of USD 114.2 million by 2034. The Solketal market expansion is estimated at a CAGR of 3.5% from ...

The study reveals lariocidin, a potent ribosome-targeting antibiotic, with unique mechanisms that could combat drug-resistant ...

Biopharmaceuticals represent another significant market segment, holding a dominant share of 44.2%. The increasing emphasis on biologics, gene therapies, and personalized medicine is fueling the ...

The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.